Testing the Effectiveness of Brief Behavioral Activation Treatment for Depression—Revised: Changes in Depression, Anxiety, Dysfunctional Attitudes, and Mindfulness
Abstract We tested the effectiveness of Brief Behavioral Activation Treatment for Depression-Revised (BATD-R), and its impact on secondary outcomes: anxiety, dysfunctional attitudes, and mindfulness. It was expected that individuals who completed BATD-R would exhibit decreased depression, anxiety, and dysfunctional attitudes, as well as increased mindfulness. A sample of adults with depression (n = 42) was recruited to complete the 10-week treatment. A healthy control group (n = 38) was included for comparison. Outcomes (depression, anxiety, dysfunctional attitudes, and mindfulness) were assessed at pre-treatment, post-treatment or 10 weeks for the healthy control group, and three-month follow-up. At pre-treatment, the clinical group reported greater depression, anxiety, and dysfunctional attitudes, and less mindfulness than the healthy control group. At post-treatment, the clinical group reported decreased depressive symptoms, trait anxiety, and dysfunctional attitudes, and increased mindfulness, compared to pre-treatment. The control group did not exhibit changes across the 10 weeks. Clinical and healthy control group post-treatment scores did not differ. At three-month follow-up, the clinical group reported a slight increase in depressive symptoms from post-treatment, but still maintained lower depressive symptoms than pre-treatment. The clinical group maintained treatment gains in dysfunctional attitudes, and mindfulness. Results support the effectiveness of BATD-R and suggest BATD-R may influence dysfunctional attitudes and mindfulness..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Journal of psychopathology and behavioral assessment - 44(2021), 2 vom: 26. Okt., Seite 456-468 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lee, Jerin [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Anxiety |
---|
Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 |
---|
doi: |
10.1007/s10862-021-09938-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2078591696 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2078591696 | ||
003 | DE-627 | ||
005 | 20230513184533.0 | ||
007 | tu | ||
008 | 221220s2021 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s10862-021-09938-4 |2 doi | |
035 | |a (DE-627)OLC2078591696 | ||
035 | |a (DE-He213)s10862-021-09938-4-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |a 150 |q VZ |
084 | |a 5,2 |2 ssgn | ||
100 | 1 | |a Lee, Jerin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Testing the Effectiveness of Brief Behavioral Activation Treatment for Depression—Revised: Changes in Depression, Anxiety, Dysfunctional Attitudes, and Mindfulness |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 | ||
520 | |a Abstract We tested the effectiveness of Brief Behavioral Activation Treatment for Depression-Revised (BATD-R), and its impact on secondary outcomes: anxiety, dysfunctional attitudes, and mindfulness. It was expected that individuals who completed BATD-R would exhibit decreased depression, anxiety, and dysfunctional attitudes, as well as increased mindfulness. A sample of adults with depression (n = 42) was recruited to complete the 10-week treatment. A healthy control group (n = 38) was included for comparison. Outcomes (depression, anxiety, dysfunctional attitudes, and mindfulness) were assessed at pre-treatment, post-treatment or 10 weeks for the healthy control group, and three-month follow-up. At pre-treatment, the clinical group reported greater depression, anxiety, and dysfunctional attitudes, and less mindfulness than the healthy control group. At post-treatment, the clinical group reported decreased depressive symptoms, trait anxiety, and dysfunctional attitudes, and increased mindfulness, compared to pre-treatment. The control group did not exhibit changes across the 10 weeks. Clinical and healthy control group post-treatment scores did not differ. At three-month follow-up, the clinical group reported a slight increase in depressive symptoms from post-treatment, but still maintained lower depressive symptoms than pre-treatment. The clinical group maintained treatment gains in dysfunctional attitudes, and mindfulness. Results support the effectiveness of BATD-R and suggest BATD-R may influence dysfunctional attitudes and mindfulness. | ||
650 | 4 | |a Behavioral activation treatment | |
650 | 4 | |a Depression | |
650 | 4 | |a Anxiety | |
650 | 4 | |a Mindfulness | |
650 | 4 | |a Dysfunctional attitudes | |
700 | 1 | |a Ford, Cameron G. |4 aut | |
700 | 1 | |a McCluskey, D. Lee |4 aut | |
700 | 1 | |a Hopkins, Patricia D. |4 aut | |
700 | 1 | |a McNeil, Daniel W. |4 aut | |
700 | 1 | |a Shook, Natalie J. |0 (orcid)0000-0002-4794-408X |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of psychopathology and behavioral assessment |d Springer US, 1985 |g 44(2021), 2 vom: 26. Okt., Seite 456-468 |w (DE-627)168085909 |w (DE-600)632689-4 |w (DE-576)01592551X |x 0882-2689 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2021 |g number:2 |g day:26 |g month:10 |g pages:456-468 |
856 | 4 | 1 | |u https://doi.org/10.1007/s10862-021-09938-4 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PSY | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
951 | |a AR | ||
952 | |d 44 |j 2021 |e 2 |b 26 |c 10 |h 456-468 |